Corakjn C Spray
Regenkine (colostrum) + hyaluronate spray — touch-free application
Medical device
50 ml
Contactless
Radiodermatitis
Corakjn C Spray allows application without direct contact: ideal for extensive areas, patients with skin hypersensitivity and contexts where direct touch is contraindicated. It combines Regenkjn (colostrum) and hyaluronate, with Calendula extract, Urea and Vitamin E. Also indicated as a support for radiodermatitis caused by radiotherapy.
- Spray application: no direct contact on the lesion.
- Concentration 1.6% + 0.02%.
- Distinctive indication: support for radiodermatitis in oncology patients.
Specification
Value
Active ingredient
Colostrum + hyaluronate
Other functional ingredients
Calendula extract, Urea, Vitamin E
Concentration
1,6% + 0,02%
Viscosity
— (spray)
pH
6,60–7,11
Volume
50 ml
Origin
Bovine (colostrum)
Shelf life
36 months
Specification
Value
Active ingredient
Colostrum + hyaluronate
Other functional ingredients
Calendula extract, Urea, Vitamin E
Concentration
1,6% + 0,02%
Viscosity
— (spray)
pH
6,60–7,11
Volume
50 ml
Origin
Bovine (colostrum)
Shelf life
36 months
The variant with the most distinctive positioning: the support for radiodermatitis hooks into the oncology segment, which is still underserved by dedicated solutions with specific documentation. For a distributor already active in oncology or hospital channels, it is a positioning opportunity with few direct competitors.
Reference channel
Oncology and radiotherapy hospital wards; hypersensitive patients and extensive lesions.
Support included
-
Complete technical documentation for all five Corakjn variants (current European regulations, in English).
- Clinical materials with a focus on specialist wound care and radiodermatitis.
- Support with positioning towards oncology and hospital channels.
- Willingness to discuss approaches for predominantly public-sector markets.
Compare the range — Corakjn cream / gel / spray
Highlighting the column of Corakjn C Spray- the product on this page.
